Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir disoproxil, Date of authorisation: 09/11/2016, Revision: 8, Status: Authorised

Human medicines European public assessment report (EPAR): Emtricitabine/Tenofovir disoproxil Zentiva, emtricitabine,tenofovir disoproxil, Date of authorisation: 09/11/2016, Revision: 8, Status: Authorised

Procedural advice for requests for the classification of variations not already listed in Commission Implementing Regulation (EU) 2021/17 or EMA/CMDv guidance on the details of the classification of variations requiring assessment according to Article 62

Procedural advice for requests for the classification of variations not already listed in Commission Implementing Regulation (EU) 2021/17 or EMA/CMDv guidance on the details of the classification of variations requiring assessment according to Article 62

Human medicines European public assessment report (EPAR): Casgevy, Exagamglogene autotemcel, Date of authorisation: 09/02/2024, Status: Authorised

Human medicines European public assessment report (EPAR): Casgevy, Exagamglogene autotemcel, Date of authorisation: 09/02/2024, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.